1848-7718
Published by: International Association of Physical Chemists
| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Chemistry | 818 | 12 | 19 | 8 |
ADMET and DMPK mainly tackles studies in Solubility, Pharmacology, Chromatography, Pharmacokinetics and Drug discovery. Solubility research featured in ADMET and DMPK incorporates concerns from various other topics such as Inorganic chemistry, Henderson–Hasselbalch equation, Thermodynamics and Dissolution. Discussions in the journal are anchored in the subject of Pharmacology and the similar topic of Metabolism.
It focuses on Chromatography but the discussions also offer insight into other areas such as Lipophilicity, Permeation and Synthetic membrane. Physiologically based pharmacokinetic modelling is a major topic of Pharmacokinetics research. The Drug discovery works featured in the journal incorporate elements from In vivo, Computational biology and ADME.
The research on In vivo featured in ADMET and DMPK combines topics in other fields like Biophysics, In vitro and Distribution (pharmacology). It focused on Drug research but expanded to cover Transporter.
The journal papers tackle a plethora of topics, such as Solubility, Pharmacology, Henderson–Hasselbalch equation, Pharmacokinetics and Drug. The studies on Solubility discussed at the published papers can also contribute to research in the domains of Inorganic chemistry, Decomposition, Amorphous solid and Nuclear chemistry. While Pharmacology is the key highlight in the most cited papers, thet also covered some subjects on Drug discovery and Drug development, In vivo, Small molecule and Computational biology.
The primary areas of discussion in ADMET and DMPK are Risk analysis (engineering), Drug, Pharmacology, hERG and Embedded system. Drug development and Current (fluid) are some topics wherein Risk analysis (engineering) research discussed in ADMET and DMPK have an impact. In it, Antimicrobial and Intensive care unit, Intensive care medicine are investigated in conjunction with one another to address concerns in Drug research.
While work presented in the journal provided substantial information on Pharmacology, it also covered topics in Anticoagulant and Drug discovery. In addition to hERG, the journal tackled discussion on research areas like Torsades de pointes, Proarrhythmia, Cardiotoxicity, QT interval and In vivo. The journal held discussions to help close the divide between two different fields of study: Embedded system and Organ-on-a-chip.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in ADMET and DMPK (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in ADMET and DMPK (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 54.55% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 20.00% were posted by at least one author from the top 10 institutions publishing in the journal. Another 60.00% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 0.00% of all publications and 20.00% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
Alex Avdeef
(2020)Alex Avdeef
(2020)Alex Avdeef;Manfred Kansy
(2020)Giuseppe Ermondi;Vasanthanathan Poongavanam;Maura Vallaro;Jan Kihlberg
(2020)Sara Soriano-Meseguer;Elisabet Fuguet;Adriana Port;Martí Rosés
(2020)Tahlia R Meola;Kara Paxton;Paul Joyce;Hayley B Schultz
(2020)Studying Chemistry in the USA opens doors to diverse career paths, many of which are supported by targeted online programs. For those interested in healthcare, transitioning to nursing through rn to bsn online programs offers a flexible way to advance clinical knowledge and career prospects without interrupting work life.
In the pharmaceutical field, accelerated paths such as an accelerated pharmd degree enable students with a foundational science background to quickly enter the industry as licensed pharmacists. This route is particularly appealing for chemistry graduates seeking expedited professional credentials.
Beyond traditional lab roles, chemistry graduates can explore sales positions in pharma companies. Understanding how much do drug reps make helps evaluate the benefits of such roles, which combine scientific knowledge with business and communication skills.
Another emerging pathway is in healthcare administration, where certifications like the certified professional coder salary highlight the financial potential in medical coding and billing careers—a beneficial option for those who want to leverage their attention to detail outside the conventional chemistry labs.
